Hanson McClain Advisors »

Neurogene shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $605 30 20.17

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Neurogene

Samsara BioCapital
Redmile Group
Casdin Capital
Rtw Investments
EcoR1 Capital
BlackRock
Baker Bros. Advisors
Trails Edge Capital Partners
Balyasny Asset Management
Toronto-Dominion Bank
Jennison Associates
Arrowpoint Asset Management
Vanguard Capital Management
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors

View all funds holding Neurogene